Delivery Order SPE2DB22D2211-SPE2DB25FSFES
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $26,659.20 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count packages) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count packaging) under a firm fixed-price contract with a ceiling value of $4,909.13. The award was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and does not utilize a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,697.80 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $10,096.14 to AmerisourceBergen Drug Corp for the supply of Rexulti 3 mg tablets (30-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,585.67 to AmerisourceBergen Drug Corp for the supply of Rexulti 3 mg tablets (30-count units) under a firm fixed-price contract. The award was made on May 23, 2025, with an ultimate completion date of May 27, 2025, and was not set-aside for small business or other designated groups. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $11,846.76 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery order and functions as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,492.36 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 8, 2025, one day following the August 7, 2025 award date. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Rexulti 2 mg tablets (30-count) with a ceiling value of $1,595.89. This non-set-aside, competitively awarded delivery order employs firm fixed price terms and is scheduled for completion by September 26, 2025. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Rexulti 2 mg tablets (30-count) with a ceiling value of $14,661.08 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of September 9, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,494.83 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package), with a completion date of September 22, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFESDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,407.85 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order represents a non-competitive award issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle that enables comprehensive medical supply distribution to military healthcare systems worldwide. The place of performance is located at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a primary supplier for the Defense Health Agency and other government healthcare systems. The company's extensive portfolio of delivery orders with the DLA demonstrates its capability to fulfill diverse pharmaceutical requirements, ranging from brand-name specialty medications to generic drugs and vaccines across multiple therapeutic domains. This particular delivery order for Rexulti, an atypical antipsychotic medication, reflects the company's ongoing role in supporting military medical supply needs through a flexible contract vehicle designed to accommodate varied and time-sensitive pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/17/25 |